Align Technology Inc

ALGN

Company Profile

  • Business description

    Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients’ teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

  • Contact

    410 North Scottsdale Road
    Suite 1300
    TempeAZ85288
    USA

    T: +1 602 742-2000

    E: [email protected]

    https://www.aligntech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2024

    Employees

    21,690

Align Technology Inc News & Analysis

markets

The world's most overvalued companies

Australian tech companies feature prominently among the top ten of frothiest names.
stocks

Finding bargains in global small to mid-cap stocks

Medical scopes, orthodontics, pet care and groceries have proved fertile ground for Bell Asset Management.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,316.7098.30-1.17%
CAC 407,274.4819.89-0.27%
DAX 4019,884.7585.11-0.43%
Dow JONES (US)42,840.26498.021.18%
FTSE 1008,084.6120.71-0.26%
HKSE19,720.7031.81-0.16%
NASDAQ19,572.60199.831.03%
Nikkei 22538,701.90111.68-0.29%
NZX 50 Index12,878.5825.53-0.20%
S&P 5005,930.8563.771.09%
S&P/ASX 2008,067.00101.20-1.24%
SSE Composite Index3,368.071.96-0.06%

Market Movers